Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0383 Transporter Info | ||||
Gene Name | SLC4A2 | ||||
Transporter Name | Anion exchange protein 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg10842164) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:2.38E-07; Z-score:-1.42E+00 | ||
Methylation in Case |
5.93E-01 (Median) | Methylation in Control | 6.87E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg10920230) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:2.96E-07; Z-score:-1.12E+00 | ||
Methylation in Case |
8.83E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg13145017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.50E+00 | Statistic Test | p-value:4.89E-07; Z-score:-1.21E+00 | ||
Methylation in Case |
3.44E-01 (Median) | Methylation in Control | 5.17E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg01971363) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.31E+00 | Statistic Test | p-value:1.07E-04; Z-score:1.13E+00 | ||
Methylation in Case |
7.99E-01 (Median) | Methylation in Control | 6.11E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg03426615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:3.44E-04; Z-score:-5.97E-01 | ||
Methylation in Case |
8.48E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04824535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:9.65E-04; Z-score:-6.52E-01 | ||
Methylation in Case |
7.68E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg06018240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:2.06E-03; Z-score:1.13E+00 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 4.81E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg02367856) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:3.75E-15; Z-score:-2.58E+00 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 8.42E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg15387987) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:5.92E-11; Z-score:-1.80E+00 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 1.99E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC4A2 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg24316073) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:1.33E-09; Z-score:-1.60E+00 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 7.57E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg10842164) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.51E+00 | Statistic Test | p-value:8.16E-12; Z-score:1.35E+01 | ||
Methylation in Case |
7.31E-01 (Median) | Methylation in Control | 4.82E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg22151713) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.47E+00 | Statistic Test | p-value:7.01E-08; Z-score:1.29E+01 | ||
Methylation in Case |
8.02E-01 (Median) | Methylation in Control | 5.47E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg06018240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:8.83E-08; Z-score:7.18E+00 | ||
Methylation in Case |
8.13E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg19502841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:1.13E-05; Z-score:4.17E+00 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 6.72E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg01971363) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.60E-03; Z-score:2.86E+00 | ||
Methylation in Case |
9.32E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg17497176) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:4.11E-03; Z-score:1.68E+00 | ||
Methylation in Case |
7.44E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg20898078) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.50E-02; Z-score:1.40E+00 | ||
Methylation in Case |
9.69E-01 (Median) | Methylation in Control | 9.57E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC4A2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg18955629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:4.21E-02; Z-score:2.77E+00 | ||
Methylation in Case |
6.05E-01 (Median) | Methylation in Control | 4.93E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg13145017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:6.00E-03; Z-score:6.85E-01 | ||
Methylation in Case |
4.01E-02 (Median) | Methylation in Control | 3.12E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg10842164) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:1.21E-02; Z-score:1.05E+00 | ||
Methylation in Case |
6.94E-01 (Median) | Methylation in Control | 6.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg10920230) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.65E-02; Z-score:2.21E-01 | ||
Methylation in Case |
1.61E-01 (Median) | Methylation in Control | 1.55E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg17497176) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:2.03E-20; Z-score:2.57E+00 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 6.69E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg19502841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.39E-10; Z-score:1.51E+00 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 7.07E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg03426615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:6.26E-10; Z-score:1.43E+00 | ||
Methylation in Case |
9.00E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg22168987) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:7.14E-07; Z-score:-1.29E+00 | ||
Methylation in Case |
6.59E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg06018240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.28E-06; Z-score:1.12E+00 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg18955629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:2.52E-03; Z-score:1.08E+00 | ||
Methylation in Case |
4.88E-01 (Median) | Methylation in Control | 4.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC4A2 in breast cancer | [ 3 ] | |||
Location |
Body (cg20898078) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:6.74E-03; Z-score:4.45E-01 | ||
Methylation in Case |
9.62E-01 (Median) | Methylation in Control | 9.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg10842164) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:4.60E-06; Z-score:2.71E+00 | ||
Methylation in Case |
7.53E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg13145017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:2.05E-02; Z-score:-5.61E-01 | ||
Methylation in Case |
2.83E-02 (Median) | Methylation in Control | 3.02E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg22168987) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:4.36E-03; Z-score:-1.76E+00 | ||
Methylation in Case |
5.95E-01 (Median) | Methylation in Control | 6.60E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg13145017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:4.71E-03; Z-score:-6.93E-01 | ||
Methylation in Case |
3.94E-02 (Median) | Methylation in Control | 4.56E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg25903588) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.47E-03; Z-score:7.18E-01 | ||
Methylation in Case |
9.51E-01 (Median) | Methylation in Control | 9.43E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg03426615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.12E-02; Z-score:-2.68E-01 | ||
Methylation in Case |
8.73E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg04824535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:2.48E-02; Z-score:1.64E-01 | ||
Methylation in Case |
9.26E-01 (Median) | Methylation in Control | 9.25E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
3'UTR (cg15387987) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:4.29E-08; Z-score:-2.09E+00 | ||
Methylation in Case |
8.18E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
3'UTR (cg02367856) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.41E-04; Z-score:-9.08E-01 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A2 in colorectal cancer | [ 5 ] | |||
Location |
3'UTR (cg24316073) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.61E-03; Z-score:-5.28E-01 | ||
Methylation in Case |
9.11E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg10842164) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.94E-04; Z-score:-6.94E-01 | ||
Methylation in Case |
6.98E-01 (Median) | Methylation in Control | 7.19E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg20122849) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:4.07E-15; Z-score:-7.11E+00 | ||
Methylation in Case |
5.45E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg22151713) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.32E+00 | Statistic Test | p-value:1.15E-08; Z-score:-1.44E+00 | ||
Methylation in Case |
3.95E-01 (Median) | Methylation in Control | 5.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg03426615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.44E-02; Z-score:-3.15E-01 | ||
Methylation in Case |
9.23E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in hepatocellular carcinoma | [ 6 ] | |||
Location |
3'UTR (cg15387987) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.25E-04; Z-score:-7.32E-01 | ||
Methylation in Case |
7.63E-01 (Median) | Methylation in Control | 7.77E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in hepatocellular carcinoma | [ 6 ] | |||
Location |
3'UTR (cg02367856) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.18E-03; Z-score:-3.48E-01 | ||
Methylation in Case |
8.57E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
5'UTR (cg13145017) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:4.38E-02; Z-score:-5.06E-01 | ||
Methylation in Case |
8.81E-02 (Median) | Methylation in Control | 9.32E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg18955629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.33E+00 | Statistic Test | p-value:7.04E-14; Z-score:-4.22E+00 | ||
Methylation in Case |
5.95E-01 (Median) | Methylation in Control | 7.94E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg17497176) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:9.51E-07; Z-score:1.40E+00 | ||
Methylation in Case |
8.46E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg01971363) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.48E-04; Z-score:-8.53E-01 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 9.14E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg22151713) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:2.74E-03; Z-score:8.79E-01 | ||
Methylation in Case |
7.23E-01 (Median) | Methylation in Control | 6.67E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg20898078) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.61E-03; Z-score:6.30E-01 | ||
Methylation in Case |
9.39E-01 (Median) | Methylation in Control | 9.34E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg04824535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.10E-02; Z-score:-6.71E-01 | ||
Methylation in Case |
8.72E-01 (Median) | Methylation in Control | 8.87E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC4A2 in papillary thyroid cancer | [ 7 ] | |||
Location |
3'UTR (cg15387987) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:1.14E-04; Z-score:1.64E+00 | ||
Methylation in Case |
7.31E-01 (Median) | Methylation in Control | 6.42E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in colon adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg11742202) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.59E+00 | Statistic Test | p-value:3.00E-03; Z-score:-1.76E+00 | ||
Methylation in Case |
1.41E-01 (Median) | Methylation in Control | 2.24E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in colon adenocarcinoma | [ 8 ] | |||
Location |
Body (cg13889508) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:4.02E-06; Z-score:-4.18E+00 | ||
Methylation in Case |
7.16E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in colon adenocarcinoma | [ 8 ] | |||
Location |
Body (cg08792812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.22E+00 | Statistic Test | p-value:6.87E-04; Z-score:-1.76E+00 | ||
Methylation in Case |
3.60E-01 (Median) | Methylation in Control | 4.41E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg27036111) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:1.28E-10; Z-score:1.81E+00 | ||
Methylation in Case |
5.41E-01 (Median) | Methylation in Control | 4.20E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg12133118) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:1.08E-03; Z-score:9.90E-01 | ||
Methylation in Case |
5.96E-01 (Median) | Methylation in Control | 5.42E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg06288351) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.33E+00 | Statistic Test | p-value:1.75E-14; Z-score:-2.37E+00 | ||
Methylation in Case |
2.36E-01 (Median) | Methylation in Control | 3.15E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg22165524) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.97E-04; Z-score:1.06E+00 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 7.49E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg15523980) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.25E-03; Z-score:-4.16E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg08411738) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:2.67E-03; Z-score:8.89E-01 | ||
Methylation in Case |
8.50E-01 (Median) | Methylation in Control | 7.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC4A2 in pancretic ductal adenocarcinoma | [ 9 ] | |||
Location |
Body (cg12583394) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:2.27E-02; Z-score:7.18E-02 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg10678459) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:2.84E-02; Z-score:1.85E+00 | ||
Methylation in Case |
7.67E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in prostate cancer | [ 10 ] | |||
Location |
Body (cg02295574) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.72E-03; Z-score:6.35E+00 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 8.77E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in prostate cancer | [ 10 ] | |||
Location |
Body (cg08450807) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:2.64E-02; Z-score:-7.72E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 9.07E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in HIV infection | [ 11 ] | |||
Location |
Body (cg03426615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:3.33E-09; Z-score:1.67E+00 | ||
Methylation in Case |
9.54E-01 (Median) | Methylation in Control | 9.25E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC4A2 in HIV infection | [ 11 ] | |||
Location |
Body (cg17497176) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:8.81E-05; Z-score:7.16E-01 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 8.71E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC4A2 in HIV infection | [ 11 ] | |||
Location |
Body (cg18955629) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.04E-02; Z-score:5.04E-01 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC4A2 in HIV infection | [ 11 ] | |||
Location |
Body (cg01971363) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:1.46E-02; Z-score:4.32E-01 | ||
Methylation in Case |
9.65E-01 (Median) | Methylation in Control | 9.61E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC4A2 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg25903588) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.04E-02; Z-score:8.93E-01 | ||
Methylation in Case |
9.21E-01 (Median) | Methylation in Control | 9.10E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
48 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-1205 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1205 | miRNA Mature ID | miR-1205 | ||
miRNA Sequence |
UCUGCAGGGUUUGCUUUGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-1253 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1253 | miRNA Mature ID | miR-1253 | ||
miRNA Sequence |
AGAGAAGAAGAUCAGCCUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-1275 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1275 | miRNA Mature ID | miR-1275 | ||
miRNA Sequence |
GUGGGGGAGAGGCUGUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon4 |
miR-1296 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1296 | miRNA Mature ID | miR-1296-3p | ||
miRNA Sequence |
GAGUGGGGCUUCGACCCUAACC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon5 |
miR-16 directly targets SLC4A2 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-16 | miRNA Mature ID | miR-16-5p | ||
miRNA Sequence |
UAGCAGCACGUAAAUAUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon6 |
miR-1909 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1909 | miRNA Mature ID | miR-1909-3p | ||
miRNA Sequence |
CGCAGGGGCCGGGUGCUCACCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon7 |
miR-194 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-194 | miRNA Mature ID | miR-194-3p | ||
miRNA Sequence |
CCAGUGGGGCUGCUGUUAUCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-3150b directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3150b | miRNA Mature ID | miR-3150b-3p | ||
miRNA Sequence |
UGAGGAGAUCGUCGAGGUUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon9 |
miR-330 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-330 | miRNA Mature ID | miR-330-3p | ||
miRNA Sequence |
GCAAAGCACACGGCCUGCAGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-34a directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-34a | miRNA Mature ID | miR-34a-5p | ||
miRNA Sequence |
UGGCAGUGUCUUAGCUGGUUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon11 |
miR-34c directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-34c | miRNA Mature ID | miR-34c-5p | ||
miRNA Sequence |
AGGCAGUGUAGUUAGCUGAUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon12 |
miR-3926 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3926 | miRNA Mature ID | miR-3926 | ||
miRNA Sequence |
UGGCCAAAAAGCAGGCAGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon13 |
miR-4418 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4418 | miRNA Mature ID | miR-4418 | ||
miRNA Sequence |
CACUGCAGGACUCAGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon14 |
miR-4434 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4434 | miRNA Mature ID | miR-4434 | ||
miRNA Sequence |
AGGAGAAGUAAAGUAGAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon15 |
miR-4447 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4447 | miRNA Mature ID | miR-4447 | ||
miRNA Sequence |
GGUGGGGGCUGUUGUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon16 |
miR-4472 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4472 | miRNA Mature ID | miR-4472 | ||
miRNA Sequence |
GGUGGGGGGUGUUGUUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon17 |
miR-449a directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-449a | miRNA Mature ID | miR-449a | ||
miRNA Sequence |
UGGCAGUGUAUUGUUAGCUGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon18 |
miR-449b directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-449b | miRNA Mature ID | miR-449b-5p | ||
miRNA Sequence |
AGGCAGUGUAUUGUUAGCUGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon19 |
miR-4516 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4516 | miRNA Mature ID | miR-4516 | ||
miRNA Sequence |
GGGAGAAGGGUCGGGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon20 |
miR-4525 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4525 | miRNA Mature ID | miR-4525 | ||
miRNA Sequence |
GGGGGGAUGUGCAUGCUGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon21 |
miR-455 directly targets SLC4A2 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-455 | miRNA Mature ID | miR-455-3p | ||
miRNA Sequence |
GCAGUCCAUGGGCAUAUACAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon22 |
miR-4665 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4665 | miRNA Mature ID | miR-4665-5p | ||
miRNA Sequence |
CUGGGGGACGCGUGAGCGCGAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon23 |
miR-4688 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4688 | miRNA Mature ID | miR-4688 | ||
miRNA Sequence |
UAGGGGCAGCAGAGGACCUGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon24 |
miR-4723 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4723 | miRNA Mature ID | miR-4723-5p | ||
miRNA Sequence |
UGGGGGAGCCAUGAGAUAAGAGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon25 |
miR-4784 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4784 | miRNA Mature ID | miR-4784 | ||
miRNA Sequence |
UGAGGAGAUGCUGGGACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon26 |
miR-484 directly targets SLC4A2 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-484 | miRNA Mature ID | miR-484 | ||
miRNA Sequence |
UCAGGCUCAGUCCCCUCCCGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon27 |
miR-486 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-486 | miRNA Mature ID | miR-486-3p | ||
miRNA Sequence |
CGGGGCAGCUCAGUACAGGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon28 |
miR-5010 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5010 | miRNA Mature ID | miR-5010-5p | ||
miRNA Sequence |
AGGGGGAUGGCAGAGCAAAAUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon29 |
miR-509 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-509 | miRNA Mature ID | miR-509-5p | ||
miRNA Sequence |
UACUGCAGACAGUGGCAAUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon30 |
miR-5698 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5698 | miRNA Mature ID | miR-5698 | ||
miRNA Sequence |
UGGGGGAGUGCAGUGAUUGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon31 |
miR-5703 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5703 | miRNA Mature ID | miR-5703 | ||
miRNA Sequence |
AGGAGAAGUCGGGAAGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon32 |
miR-6132 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6132 | miRNA Mature ID | miR-6132 | ||
miRNA Sequence |
AGCAGGGCUGGGGAUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon33 |
miR-615 directly targets SLC4A2 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-615 | miRNA Mature ID | miR-615-3p | ||
miRNA Sequence |
UCCGAGCCUGGGUCUCCCUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon34 |
miR-625 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-625 | miRNA Mature ID | miR-625-5p | ||
miRNA Sequence |
AGGGGGAAAGUUCUAUAGUCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon35 |
miR-6722 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6722 | miRNA Mature ID | miR-6722-3p | ||
miRNA Sequence |
UGCAGGGGUCGGGUGGGCCAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon36 |
miR-6743 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6743 | miRNA Mature ID | miR-6743-5p | ||
miRNA Sequence |
AAGGGGCAGGGACGGGUGGCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon37 |
miR-6807 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6807 | miRNA Mature ID | miR-6807-3p | ||
miRNA Sequence |
CACUGCAUUCCUGCUUGGCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon38 |
miR-6825 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6825 | miRNA Mature ID | miR-6825-5p | ||
miRNA Sequence |
UGGGGAGGUGUGGAGUCAGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon39 |
miR-6835 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6835 | miRNA Mature ID | miR-6835-3p | ||
miRNA Sequence |
AAAAGCACUUUUCUGUCUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon40 |
miR-6836 directly targets SLC4A2 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6836 | miRNA Mature ID | miR-6836-5p | ||
miRNA Sequence |
CGCAGGGCCCUGGCGCAGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon41 |
miR-6870 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6870 | miRNA Mature ID | miR-6870-5p | ||
miRNA Sequence |
UGGGGGAGAUGGGGGUUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon42 |
miR-7106 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7106 | miRNA Mature ID | miR-7106-5p | ||
miRNA Sequence |
UGGGAGGAGGGGAUCUUGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon43 |
miR-7109 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7109 | miRNA Mature ID | miR-7109-5p | ||
miRNA Sequence |
CUGGGGGGAGGAGACCCUGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon44 |
miR-7111 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7111 | miRNA Mature ID | miR-7111-5p | ||
miRNA Sequence |
UGGGGGAGGAAGGACAGGCCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon45 |
miR-765 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-765 | miRNA Mature ID | miR-765 | ||
miRNA Sequence |
UGGAGGAGAAGGAAGGUGAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon46 |
miR-8087 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-8087 | miRNA Mature ID | miR-8087 | ||
miRNA Sequence |
GAAGACUUCUUGGAUUACAGGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon47 |
miR-92a directly targets SLC4A2 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-92a | miRNA Mature ID | miR-92a-3p | ||
miRNA Sequence |
UAUUGCACUUGUCCCGGCCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon48 |
miR-944 directly targets SLC4A2 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-944 | miRNA Mature ID | miR-944 | ||
miRNA Sequence |
AAAUUAUUGUACAUCGGAUGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.